Journey Medical Corporation Enters $7.5 Million Line of Credit Agreement with East West Bank Apr 05, 2021
Journey Medical Corporation Enters into a Definitive Agreement with Dermira, Inc., a Wholly-Owned Subsidiary of Eli Lilly and Company, to Acquire QBREXZA® Apr 01, 2021
Fortress Biotech’s Partner Company, Journey Medical Corporation, In-licenses and Launches Accutane® for the Treatment of Severe Recalcitrant Nodular Acne Mar 22, 2021
Checkpoint Therapeutics Reports Full-Year 2020 Financial Results and Recent Corporate Highlights Mar 09, 2021
Checkpoint Therapeutics to Participate in H.C. Wainwright Global Life Sciences Virtual Conference Mar 04, 2021
